Email Password

Remember me

Forgotten your login?

Promo

Companies A-Z

0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Key contact

Haran Siva

Haran Siva, Director
hsiva@edisoninvestmentresearch.com

Edison Investment Research Limited - Australia
71 York Street
Sydney
NSW 2000
Australia
Tel: +61 (0)2 8060 4880

Press release - Edison opens Australian office

listed companies

Nkwe Platinum Gold One
Bionomics Phylogica
ADX Energy Alkane Resources
Sumatra Copper & Gold Continental Coal
Gunson Resources RedFlow
Circadian Technologies Universal Coal
Biotron Slater & Gordon
Clinuvel Wolf Minerals
Pharmaxis

Companies with HQs in asia-pacific

Seeing Machines Range Resources
Treasury China Trust Coal of Africa
Bezant Resources Allied Gold Mining
Baobab Resources Bellzone Mining
Endace Lochard Energy

Fast facts

9,700
Asia-Pacific database
315
Number of corporate clients
101
Number of countries where investors read our research
350
Number of stocks under coverage

Latest research

Pan African Resources

Interim results

Flash note | Mining | 22/02/2012

In its first half to December 2011, Pan African Resources (PAF) achieved an 88.7% year-on-year (y-o-y) increase in EPS to 1.0pps on a 33.7% increase in…

Sucampo Pharmaceuticals

Fighting Amitiza’s corner

QuickView | Pharmaceutical & Healthcare | 22/02/2012

Sucampo will hear within a couple of months whether it has been successful in its attempt to reclaim US commercial rights from Takeda to Amitiza (lubiprostone),…

Rathbone Brothers

Stability during volatility

QuickView | Investment Companies | 22/02/2012

Investment summary: Stability during volatility Throughout a year of high volatility, Rathbone Brothers recorded a 20% increase in profit before tax driven…

Photocure

Building a US operation

QuickView | Pharmaceutical & Healthcare | 22/02/2012

FY11 results showed sales and royalties of NOK82.9m. Milestones on the Ipsen European Hexvix (bladder cancer imaging) marketing deal added NOK32.7m making…

Neovacs

CD data to spur deals?

QuickView | Pharmaceutical & Healthcare | 22/02/2012

Neovacs aims to license its lead product, TNFα-kinoid, on the back of results – due in Q2 – from a Phase II study in Crohn’s disease…

Edison asia-pacific

Edison Investment Research is widely recognised as a leading international independent investment research company. Edison opened a Sydney office in 2011 to provide our Research Service in Australia and the Asia-Pacific region. Companies of all sizes benefit from our Research Service, where we provide the highest standards of research and unrivaled distribution of our reports on a global and unrestricted basis.

 

See more reports See more reports See more reports

 

See more sector reports See more sector reports


Sectors covered by Edison's research teams